Skip to main content
. 2022 Mar 24;13:826132. doi: 10.3389/fgene.2022.826132

TABLE 4.

Experience with the use of hydroxyurea

Experience Before using HU n (%) Currently using HU n (%)
Number of VOC per year
0–1 47 (12.5) 240 (63.5)
2–3 140 (37) 92 (24.4)
4–5 106 (28.1) 29 (7.7)
6–7 29 (7.7) 4 (1.1)
>7 53 (14) 9 (2.5)
Number of hospital admission per year
0–1 161 (42.6) 308 (81.5)
2–3 129 (34.1) 50 (13.2)
4–5 57 (15.1) 15 (4.0)
6–7 13 (3.5) 1 (0.3)
>7 16 (4.4) 1 (0.3)
Number of transfusion
0 123 (32.5) 260 (68.8)
1–3 187 (49.5) 77 (20.4)
>3 45 (11.9) 15 (4.0)
PCV%
<20 36 (21.4) 8 (4.8)
20–25 106 (63.1) 64 (38.1)
>25 26 (15.5) 96 (57.1)
Minimum PCV (Min) 14% 18%
Maximum PCV (Max) 39% 39%